Omnicell EBITDA Margin 2010-2025 | OMCL

Current and historical EBITDA (Earnings Before Interest, Taxes, Depreciation and Amortization) margin for Omnicell (OMCL) over the last 10 years. The current EBITDA margin for Omnicell as of March 31, 2025 is .
Omnicell EBITDA Margin Historical Data
Date TTM Revenue TTM EBITDA EBITDA Margin
2025-03-31 $1.14B $0.10B 8.98%
2024-12-31 $1.11B $0.09B 8.36%
2024-09-30 $1.06B $0.06B 5.64%
2024-06-30 $1.08B $0.06B 5.46%
2024-03-31 $1.10B $0.07B 5.89%
2023-12-31 $1.15B $0.07B 5.66%
2023-09-30 $1.19B $0.05B 4.21%
2023-06-30 $1.24B $0.07B 5.34%
2023-03-31 $1.27B $0.07B 5.68%
2022-12-31 $1.30B $0.10B 7.79%
2022-09-30 $1.31B $0.15B 11.76%
2022-06-30 $1.26B $0.17B 13.21%
2022-03-31 $1.20B $0.18B 15.18%
2021-12-31 $1.13B $0.20B 17.40%
2021-09-30 $1.07B $0.20B 18.97%
2021-06-30 $0.99B $0.18B 17.71%
2021-03-31 $0.92B $0.13B 14.21%
2020-12-31 $0.89B $0.11B 12.65%
2020-09-30 $0.89B $0.11B 11.88%
2020-06-30 $0.91B $0.12B 13.23%
2020-03-31 $0.92B $0.15B 15.69%
2019-12-31 $0.90B $0.15B 16.16%
2019-09-30 $0.86B $0.14B 16.14%
2019-06-30 $0.84B $0.13B 15.31%
2019-03-31 $0.81B $0.11B 13.99%
2018-12-31 $0.79B $0.10B 12.44%
2018-09-30 $0.77B $0.10B 12.31%
2018-06-30 $0.76B $0.09B 11.79%
2018-03-31 $0.75B $0.08B 10.98%
2017-12-31 $0.71B $0.06B 8.98%
2017-09-30 $0.69B $0.06B 9.25%
2017-06-30 $0.68B $0.06B 8.65%
2017-03-31 $0.67B $0.06B 9.05%
2016-12-31 $0.70B $0.08B 11.78%
2016-09-30 $0.65B $0.07B 10.91%
2016-06-30 $0.60B $0.07B 11.85%
2016-03-31 $0.54B $0.08B 13.91%
2015-12-31 $0.48B $0.07B 15.29%
2015-09-30 $0.48B $0.07B 15.55%
2015-06-30 $0.46B $0.07B 15.73%
2015-03-31 $0.46B $0.07B 15.57%
2014-12-31 $0.44B $0.07B 15.84%
2014-09-30 $0.43B $0.07B 15.73%
2014-06-30 $0.41B $0.06B 15.48%
2014-03-31 $0.40B $0.06B 15.15%
2013-12-31 $0.38B $0.05B 14.17%
2013-09-30 $0.37B $0.05B 14.25%
2013-06-30 $0.36B $0.05B 14.65%
2013-03-31 $0.34B $0.04B 12.80%
2012-12-31 $0.31B $0.04B 12.78%
2012-09-30 $0.29B $0.03B 11.89%
2012-06-30 $0.27B $0.03B 9.77%
2012-03-31 $0.25B $0.03B 10.71%
2011-12-31 $0.25B $0.02B 9.80%
2011-09-30 $0.24B $0.02B 8.37%
2011-06-30 $0.23B $0.02B 7.79%
2011-03-31 $0.23B $0.02B 8.00%
2010-12-31 $0.22B $0.02B 8.56%
2010-09-30 $0.22B $0.02B 8.64%
2010-06-30 $0.22B $0.02B 7.80%
2010-03-31 $0.22B $0.02B 6.94%
2009-12-31 $0.21B $0.01B 5.14%
Sector Industry Market Cap Revenue
Medical Medical Information Systems $1.423B $1.112B
Omnicell Inc., develops and markets end-to-end automation solutions for the medication-use process. These automation solutions contain medication and supply dispensing systems, central pharmacy storage, retrieval and packaging solutions, a bedside automation solution, a physician order management solution, a decision support application, and a Web-based procurement application. The products offered by the company enable care providers to improve patient safety and increase efficiency by lowering costs. The company also adheres to regulatory compliances and addresses issues related to population health.
Stock Name Country Market Cap PE Ratio
Veeva Systems (VEEV) United States $45.506B 58.15
Hims & Hers Health (HIMS) United States $12.660B 131.53
Tempus AI (TEM) United States $9.553B 0.00
IRhythm Technologies (IRTC) United States $4.485B 0.00
Inspire Medical Systems (INSP) United States $4.076B 63.69
Privia Health (PRVA) United States $2.775B 189.67
Enovis (ENOV) United States $1.788B 9.97
Clover Health Investments (CLOV) United States $1.598B 0.00
Schrodinger (SDGR) United States $1.586B 0.00
Phreesia (PHR) United States $1.457B 0.00
Azenta (AZTA) United States $1.223B 56.85
10x Genomics (TXG) United States $1.173B 0.00
Claritev (CTEV) United States $0.632B 0.00
Fulgent Genetics (FLGT) United States $0.631B 0.00
Butterfly Network (BFLY) United States $0.593B 0.00
Talkspace (TALK) United States $0.534B 159.50
Veradigm (MDRX) United States $0.466B 0.00
Standard BioTools (LAB) United States $0.384B 0.00
TruBridge (TBRG) United States $0.360B 797.67
Outset Medical (OM) United States $0.311B 0.00
Health Catalyst (HCAT) United States $0.264B 0.00
Nyxoah SA (NYXH) Belgium $0.261B 0.00
SOPHiA GENETICS SA (SOPH) Switzerland $0.200B 0.00
Pulmonx (LUNG) United States $0.137B 0.00
EUDA Health Holdings (EUDA) Singapore $0.136B 0.00
KORU Medical Systems (KRMD) United States $0.125B 0.00
American Well (AMWL) United States $0.105B 0.00
MDxHealth SA (MDXH) Belgium $0.100B 0.00
CareCloud (CCLD) United States $0.085B 3.26
111 (YI) China $0.071B 0.00
HeartBeam (BEAT) United States $0.057B 0.00
P3 Health Partners (PIII) United States $0.053B 0.00
Zepp Health (ZEPP) Netherlands $0.037B 0.00
Zhongchao (ZCMD) China $0.029B 0.00
ImmunoPrecise Antibodies (IPA) Canada $0.026B 0.00
Streamline Health Solutions (STRM) United States $0.022B 0.00
Bullfrog AI Holdings (BFRG) United States $0.016B 0.00
Precipio (PRPO) United States $0.014B 0.00
MSP Recovery (MSPR) United States $0.010B 0.00
Strata Skin Sciences (SSKN) United States $0.010B 0.00
Predictive Oncology (POAI) United States $0.008B 0.00
Mobile-health Network Solutions (MNDR) Singapore $0.004B 0.00
Movano (MOVE) United States $0.004B 0.00
HeartSciences (HSCS) United States $0.004B 0.00
Tivic Health Systems (TIVC) United States $0.004B 0.00
Evaxion - (EVAX) Denmark $0.003B 0.00
Healthcare Triangle (HCTI) United States $0.000B 0.00
Future Health ESG (FHLT) United States $0.000B 0.00